PHARMACEUTICAL INDUSTRY FACES AN "INNOVATION DEFICIT," HOFFMANN-LA ROCHE EXEC SUGGESTS; ALLIANCES WITH BIOTECH COULD MITIGATE DOWNWARD TREND IN NMEs
Executive Summary
The pharmaceutical industry "doesn't generate enough interesting compounds that can satisfy and sustain its growth," Hoffmann-La Roche International R&D President Jurgen Drews, MD, declared in a Nov. 8 keynote speech to the Oppenheimer & Co. health care conference in New York City.